Patient demographics and baseline characteristics
| Quinapril | Placebo | |
|---|---|---|
| n | 20 | 20 |
| Age (years) | 35.2 | 39.6 |
| Sex (M/F) | 11/9 | 12/8 |
| BMI (kg/m2) | 29.8 | 29.1 |
| Systolic blood pressure (mmHg) | 126 ± 8 | 130 ± 9 |
| Diastolic blood pressure (mmHg) | 80 ± 10.4 | 77.8 ± 11.1 |
| LDL cholesterol (mg/dl) | 124.7 ± 21.4 | 130 ± 16.8 |
| HDL cholesterol (mg/dl) | 40.3 ± 7.0 | 38.9 ± 6.1 |
| Triglycerides (mg/dl) | 238 ± 36 | 219 ± 30 |
| Fasting glucose (mg/dl) | 113 ± 15 | 111 ± 19 |
| HbA1c (%) | 5.8 ± 0.7 | 5.6 ± 0.8 |
| Hypertension | 5 (25) | 6 (30) |
| Smoking history | 7 (35) | 6 (30) |
| Concomitant medications | ||
| Lipid lowering therapy* | 5 (25) | 6 (30) |
| β-Blocker | 2 (10) | 4 (20) |
| Diuretic | 3 (15) | 4 (20) |
| Calcium channel blocker | 3 (15) | 4 (20) |
Data are means ± SE or n (%).
↵* Includes statin, niacin, resin, or fibrates.